
Father, Neonatologist, Epidemiologist- working to improve neonatal outcomes #comparativeeffectiveness #pharmacoepidemiology @nchfordocs
Columbus, OH
Joined May 2018
- Tweets421
- Following311
- Followers396
- Likes1.9K
Households in the contiguous United States will pay thousands of dollars more for energy through 2040 because of federal policy changes since President Trump returned to office, according to modeling released Friday by a nonpartisan think tank. abcnews.link/iqA2Txc
Jonathan L Slaughter, MD, MPH retweeted
Among male children in a US prospective cohort, neonatal male circumcision was not associated with #AutismSpectrumDisorder diagnosis after adjustment for confounders. ja.ma/4hbrwJk
Jonathan L Slaughter, MD, MPH retweeted
A new formula to estimate oxygenation index (OI) from Oxygen Saturation Index (OSI) in #CDH @CDHTop10 sciencedirect.com/science/ar… @cdhintl from @NIH Neonatal research network: OI=0.6*OSI+0.08*OSI*OSI+2.6 a complex formula but provides a better fit for high OSI values in CDH
Jonathan L Slaughter, MD, MPH retweeted
Among extremely #preterm infants, prophylactic acetaminophen for patent ductus arteriosus accelerated ductal closure but did not increase survival without severe #neonatal morbidity at 36 weeks and was associated with higher rates of cholestasis.
ja.ma/3OaU0q9
Jonathan L Slaughter, MD, MPH retweeted
📊 Research Summary: Expectant management among infants with patent ductus arteriosus did not lower the risk of death or BPD compared with active treatment, but more infants survived in the expectant management group.
@Nemours #HotTopicsNeo2025
ja.ma/3MOvc6h
Jonathan L Slaughter, MD, MPH retweeted
Among preterm infants born at 22 to 28 weeks’ gestation with a protocol-defined patent ductus arteriosus, does expectant management compared with active treatment decrease the incidence of death or bronchopulmonary dysplasia? #HotTopicsNeo2025
📽️ Watch the video and read the full article: ja.ma/4pZwV7m
Jonathan L Slaughter, MD, MPH retweeted
With the publication of the NICHD PDA Trial, we revisit PDA in Prematurity: Rethinking a Decades-Old Debate (2025). In 482 infants (22–28 wks), expectant management showed no difference in death/BPD vs treatment and higher survival.
neocardiolab.com/tnecho-and-…
Jonathan L Slaughter, MD, MPH retweeted
What’s the best way to manage a PDA? New evidence from Laughon et al.
A summary plus appraisal. Let me know if you notice any errors or have other thoughts about this study.
Jonathan L Slaughter, MD, MPH retweeted
#neotwitter....From the NICHD NRN (congratulations to Matthew Laughon and others): Expectant Management vs Medication for Patent Ductus Arteriosus in Preterm Infants jamanetwork.com/journals/jam…
Jonathan L Slaughter, MD, MPH retweeted
Looking forward to @HotTopicsNeo !
New study out on car seat testing (CSTS) in neonates. Large sample of 2861 CSTS in #preemies before discharge.
After failing a CSTS mean of 2 days to pass and 77% will pass second test!
What does this test tell us?
@BrianKingNeo
#neotwitter
Jonathan L Slaughter, MD, MPH retweeted
Is Academic Neonatology at the Brink of Extinction? How can Departments of Pediatrics recruit and retain excellent clinicians who inspire students and residents to join Neonatal fellowship? @AAPneonatal @WomenNeo youtu.be/6UWJmAZk0Gc?si=UAyg… via @YouTube @nicupodcast
Jonathan L Slaughter, MD, MPH retweeted
Practical perspective on the risk benefit ratio of probiotics in preterm babies 💡 Incidence of probiotic sepsis and morbidity risk in premature infants: a meta-analysis | Pediatric Research nature.com/articles/s41390-0…
Jonathan L Slaughter, MD, MPH retweeted
Upgrade your #causalinference arsenal.
A revision of our book "Causal Inference: What If" is available at miguelhernan.org/whatifbook
Thanks to everyone who suggested improvements, reported typos, and proposed new citations and material.
Enjoy the #WhatIfBook. Also, it's free.
Jonathan L Slaughter, MD, MPH retweeted
Replying to @ambaln
Am not sure about the title of the talk, the objectives and the audience. But IMO the key high-level problems with BPD to be highlighted are
1. We are continuing to use a definition based on the treatment given, not on the disease pathology or pathophysiology.
2. The certainty of evidence for how we assess and manage BPD is low. There have been hardly any RCTs on evolving or established BPD. Yet, in the absence of high certainty evidence groups have formulated recommendations and guidelines based merely on expert opinion and low-level evidence. These guidelines have become established in practice, and have created a lack of equipoise for rigorous studies. Every NICU has its own set of beliefs and traditions on how to manage BPD.
3. We know very little about how to transition babies with BPD to the home (or institutional) setting and how to manage them after the transition. This includes care and support of the parents.
Jonathan L Slaughter, MD, MPH retweeted
If you look back at all the research and experience in Neonatology over the past 30 years, what is the main message that emerges? IMO it is “Less is More”. We used to think that more intervention is better, and more aggressive, earlier interventions are better. Instead we have learned the opposite is true.
#neotwitter
Jonathan L Slaughter, MD, MPH retweeted
Updated meta-regression by @ProfLexDoyle et al. examines how potential benefit from Dexamethasone and Hydrocortisone changes with baseline risk of BPD among included trials. #neoEBM #neotwitter #EBNEOalerts @JAMAPediatrics
buff.ly/3CNa6Ae
Jonathan L Slaughter, MD, MPH retweeted
Look how many investigators it takes to conduct a decent sized perinatal RCT… 🙏🏻 🙏🏻 🙏🏻
Jonathan L Slaughter, MD, MPH retweeted
📄Exploring perinatal HIE in a large public hospital population: Insights from our study now published in @JAMANetworkOpen 👇🏼🌟
@lina_chalak @DrSriniKota @utswpediatrics @utswnews
The changing incidence of hypoxic-ischemic encephalopathy (HIE) is primarily due to improved documentation of mild HIE. ja.ma/4hIFkbJ
Jonathan L Slaughter, MD, MPH retweeted
Results of the @plusstrial (Intratracheal Budesonide Mixed With Surfactant for Extremely Preterm Infants) led by @drbretty published in @jama_current:
Paper: buff.ly/48Kmhtz
Editorial: buff.ly/40HxadL
#neoEBM #EBNEOAlerts #neoTwitter
Jonathan L Slaughter, MD, MPH retweeted
Great news! Join our fabulous workshop on Trustworthiness of research led by @Dr_Rasheda with our @EBNEO team @Atul_Monash @BrianKingNeo at Hawai @PASMeeting

























